Advertisement
New Zealand markets closed
  • NZX 50

    11,744.39
    +2.92 (+0.02%)
     
  • NZD/USD

    0.6089
    +0.0001 (+0.02%)
     
  • NZD/EUR

    0.5628
    -0.0001 (-0.02%)
     
  • ALL ORDS

    8,007.10
    +47.60 (+0.60%)
     
  • ASX 200

    7,745.60
    +46.90 (+0.61%)
     
  • OIL

    78.47
    +0.21 (+0.27%)
     
  • GOLD

    2,048.40
    -6.30 (-0.31%)
     
  • NASDAQ

    18,043.85
    +169.35 (+0.95%)
     
  • FTSE

    7,666.88
    +36.86 (+0.48%)
     
  • Dow Jones

    38,996.39
    +47.37 (+0.12%)
     
  • DAX

    17,746.93
    +68.74 (+0.39%)
     
  • Hang Seng

    16,589.44
    +78.00 (+0.47%)
     
  • NIKKEI 225

    39,910.82
    +744.63 (+1.90%)
     
  • NZD/JPY

    91.6310
    +0.3710 (+0.41%)
     

Eli Lilly and Company (NYSE:LLY) is largely controlled by institutional shareholders who own 85% of the company

Every investor in Eli Lilly and Company (NYSE:LLY) should be aware of the most powerful shareholder groups. With 85% stake, institutions possess the maximum shares in the company. Put another way, the group faces the maximum upside potential (or downside risk).

Because institutional owners have a huge pool of resources and liquidity, their investing decisions tend to carry a great deal of weight, especially with individual investors. As a result, a sizeable amount of institutional money invested in a firm is generally viewed as a positive attribute.

Let's delve deeper into each type of owner of Eli Lilly, beginning with the chart below.

See our latest analysis for Eli Lilly

ownership-breakdown
ownership-breakdown

What Does The Institutional Ownership Tell Us About Eli Lilly?

Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger companies that are included in the relevant benchmark index.

Eli Lilly already has institutions on the share registry. Indeed, they own a respectable stake in the company. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. If multiple institutions change their view on a stock at the same time, you could see the share price drop fast. It's therefore worth looking at Eli Lilly's earnings history below. Of course, the future is what really matters.

earnings-and-revenue-growth
earnings-and-revenue-growth

Institutional investors own over 50% of the company, so together than can probably strongly influence board decisions. We note that hedge funds don't have a meaningful investment in Eli Lilly. Looking at our data, we can see that the largest shareholder is Lilly Endowment, Inc, Endowment Arm with 11% of shares outstanding. In comparison, the second and third largest shareholders hold about 7.6% and 6.7% of the stock.

After doing some more digging, we found that the top 11 have the combined ownership of 51% in the company, suggesting that no single shareholder has significant control over the company.

Researching institutional ownership is a good way to gauge and filter a stock's expected performance. The same can be achieved by studying analyst sentiments. There are plenty of analysts covering the stock, so it might be worth seeing what they are forecasting, too.

Insider Ownership Of Eli Lilly

The definition of an insider can differ slightly between different countries, but members of the board of directors always count. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.

I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.

Our data suggests that insiders own under 1% of Eli Lilly and Company in their own names. Being so large, we would not expect insiders to own a large proportion of the stock. Collectively, they own US$427m of stock. It is good to see board members owning shares, but it might be worth checking if those insiders have been buying.

General Public Ownership

The general public-- including retail investors -- own 15% stake in the company, and hence can't easily be ignored. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.

Next Steps:

I find it very interesting to look at who exactly owns a company. But to truly gain insight, we need to consider other information, too. Be aware that Eli Lilly is showing 2 warning signs in our investment analysis , you should know about...

But ultimately it is the future, not the past, that will determine how well the owners of this business will do. Therefore we think it advisable to take a look at this free report showing whether analysts are predicting a brighter future.

NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You’ll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here